Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study Meeting Abstract


Authors: Reiss, S.; Yerram, P.; Modelevsky, L.; Grommes, C.
Abstract Title: Rituximab, methotrexate, BCNU, etoposide, and prednisone (RMBVP) for the treatment of relapsed/recurrent primary central nervous system lymphoma: A retrospective single center study
Meeting Title: 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 21
Issue: Suppl. 6
Meeting Dates: 2019 Nov 22-24
Meeting Location: Phoenix, AZ
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: vi232
Language: English
ACCESSION: WOS:000509478705114
PROVIDER: wos
PMCID: PMC6846926
DOI: 10.1093/neuonc/noz175.1194
Notes: Meeting Abstract: RARE-51 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christian Grommes
    150 Grommes
  2. Samantha Nicole Reiss
    14 Reiss
  3. Prakirthi Yerram
    9 Yerram